Keywords: kissei, existing, business, flat, pipeline, lead, growth

Kissei's existing business flat but R&D pipeline should lead to growth in

Article | 10 August 2000

Print This

Kissei Pharmaceuticals of Japan recently hosted a visit from analysts atHSBC which saw the company in confident mood regarding the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in